Search and Browse
Download
Enter Data
| Reaction Details | |||
|---|---|---|---|
 | Report a problem with these data | ||
| Target | Prothrombin | ||
| Ligand | BDBM50060706 | ||
| Substrate/Competitor | n/a | ||
| Meas. Tech. | ChEMBL_208549 (CHEMBL814318) | ||
| Ki | 8.0±n/a nM | ||
| Citation |  Tucker, TJ; Lumma, WC; Lewis, SD; Gardell, SJ; Lucas, BJ; Sisko, JT; Lynch, JJ; Lyle, EA; Baskin, EP; Woltmann, RF; Appleby, SD; Chen, IW; Dancheck, KB; Naylor-Olsen, AM; Krueger, JA; Cooper, CM; Vacca, JP Synthesis of a series of potent and orally bioavailable thrombin inhibitors that utilize 3,3-disubstituted propionic acid derivatives in the P3 position. J Med Chem40:3687-93 (1997) [PubMed] Article | ||
| More Info.: | Get all data from this article, Assay Method | ||
| Prothrombin | |||
| Name: | Prothrombin | ||
| Synonyms: | Activation peptide fragment 1 | Activation peptide fragment 2 | Coagulation factor II | F2 | Prothrombin precursor | THRB_HUMAN | Thrombin heavy chain | Thrombin light chain | ||
| Type: | Protein | ||
| Mol. Mass.: | 70029.57 | ||
| Organism: | Homo sapiens (Human) | ||
| Description: | P00734 | ||
| Residue: | 622 | ||
| Sequence: |
| ||
| BDBM50060706 | |||
| n/a | |||
| Name | BDBM50060706 | ||
| Synonyms: | (S)-1-(3-Cyclohexyl-3-phenyl-propionyl)-pyrrolidine-2-carboxylic acid (4-amino-cyclohexylmethyl)-amide; TFA | CHEMBL408125 | ||
| Type | Small organic molecule | ||
| Emp. Form. | C27H41N3O2 | ||
| Mol. Mass. | 439.6333 | ||
| SMILES | NC1CCC(CNC(=O)[C@@H]2CCCN2C(=O)CC(C2CCCCC2)c2ccccc2)CC1 |wU:9.8,(12.27,-11.37,;11.3,-10.18,;9.99,-9.41,;10.63,-7.71,;10.21,-6.56,;8.83,-5.91,;8.67,-4.37,;7.26,-3.76,;6.01,-4.66,;7.1,-2.22,;8.26,-1.2,;7.61,.21,;6.11,.05,;5.79,-1.45,;4.37,-2.06,;4.21,-3.6,;3.12,-1.17,;3.12,.37,;4.44,1.14,;4.44,2.68,;5.75,3.45,;7.1,2.68,;7.1,1.14,;5.79,.37,;1.78,1.14,;.43,.37,;-.89,1.14,;-.89,2.68,;.43,3.45,;1.78,2.68,;11.56,-7.33,;10.92,-8.93,)| | ||
| Structure | 
| ||